200 related articles for article (PubMed ID: 21258101)
1. New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?
Bonomo RA
Clin Infect Dis; 2011 Feb; 52(4):485-7. PubMed ID: 21258101
[No Abstract] [Full Text] [Related]
2. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase.
Sidjabat H; Nimmo GR; Walsh TR; Binotto E; Htin A; Hayashi Y; Li J; Nation RL; George N; Paterson DL
Clin Infect Dis; 2011 Feb; 52(4):481-4. PubMed ID: 21258100
[TBL] [Abstract][Full Text] [Related]
3. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Shah PM
Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
[No Abstract] [Full Text] [Related]
4. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Poulou A; Spanakis N; Pournaras S; Pitiriga V; Ranellou K; Markou F; Tsakris A
J Antimicrob Chemother; 2010 Dec; 65(12):2538-42. PubMed ID: 20876622
[TBL] [Abstract][Full Text] [Related]
5. New Delhi metallo-beta-lactamase, Ontario, Canada.
Tijet N; Alexander DC; Richardson D; Lastovetska O; Low DE; Patel SN; Melano RG
Emerg Infect Dis; 2011 Feb; 17(2):306-7. PubMed ID: 21291614
[No Abstract] [Full Text] [Related]
6. A VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Weile J; Ohler S; Schönthal S; Knabbe C
Int J Antimicrob Agents; 2009 Apr; 33(4):389-91. PubMed ID: 19108993
[No Abstract] [Full Text] [Related]
7. Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Panagiotakopoulou A; Daikos GL; Miriagou V; Loli A; Tzelepi E; Tzouvelekis LS
Int J Antimicrob Agents; 2007 Mar; 29(3):360-2. PubMed ID: 17223016
[No Abstract] [Full Text] [Related]
8. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase.
Naas T; Cuzon G; Babics A; Fortineau N; Boytchev I; Gayral F; Nordmann P
J Antimicrob Chemother; 2010 Jun; 65(6):1305-6. PubMed ID: 20382724
[No Abstract] [Full Text] [Related]
9. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
[No Abstract] [Full Text] [Related]
10. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
[No Abstract] [Full Text] [Related]
11. Multiclonal emergence of carbapenem-resistant Klebsiella pneumoniae in Tuscany, Italy.
Mammina C; Aleo A; Bonura C; Calà C; Degl'Innocenti R; Conti A; Pecile P; Pesavento G; Nastasi A
Int J Antimicrob Agents; 2010 Dec; 36(6):576-8. PubMed ID: 20869854
[No Abstract] [Full Text] [Related]
12. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
Nagaraj S; Chandran SP; Shamanna P; Macaden R
Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
[TBL] [Abstract][Full Text] [Related]
13. Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France.
Levast M; Poirel L; Carrër A; Deiber M; Decroisette E; Mallaval FO; Lecomte C; Nordmann P
J Antimicrob Chemother; 2011 Apr; 66(4):944-5. PubMed ID: 21393135
[No Abstract] [Full Text] [Related]
14. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Roy S; Viswanathan R; Singh AK; Das P; Basu S
J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155
[No Abstract] [Full Text] [Related]
15. Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland.
Poirel L; Lienhard R; Potron A; Malinverni R; Siegrist HH; Nordmann P
J Antimicrob Chemother; 2011 Mar; 66(3):675-6. PubMed ID: 21193473
[No Abstract] [Full Text] [Related]
16. Detection of GES-5-producing Klebsiella pneumoniae in Brazil.
Picão RC; Santos AF; Nicoletti AG; Furtado GH; Gales AC
J Antimicrob Chemother; 2010 Apr; 65(4):796-7. PubMed ID: 20139141
[No Abstract] [Full Text] [Related]
17. In vitro emergence of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae clinical isolates.
Villar HE; Santana G; Jugo MB; Perren P; Hidalgo M; Alonso P; Maccallini G
J Infect Dev Ctries; 2015 Feb; 9(2):218-21. PubMed ID: 25699499
[No Abstract] [Full Text] [Related]
18. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia.
Cuzon G; Naas T; Lesenne A; Benhamou M; Nordmann P
Int J Antimicrob Agents; 2010 Jul; 36(1):91-3. PubMed ID: 20356714
[No Abstract] [Full Text] [Related]
20. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon.
Matar GM; Cuzon G; Araj GF; Naas T; Corkill J; Kattar MM; Nordmann P
Clin Microbiol Infect; 2008 Sep; 14(9):887-8. PubMed ID: 18844693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
